Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationGranulocyte Colony-Stimulating FactorCombined Modality TherapyTransplantation ConditioningLeukapheresisTransplantation, HomologousAntineoplastic Combined Chemotherapy ProtocolsCyclophosphamideMelphalanBlood Component RemovalAntigens, CD34Hematologic NeoplasmsTreatment OutcomeStem Cell TransplantationMultiple MyelomaGraft vs Host DiseaseLymphoma, Non-HodgkinHematopoietic Stem CellsBusulfanMyeloablative AgonistsBone Marrow TransplantationGraft SurvivalStem CellsEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceSalvage TherapyIfosfamideCarmustineCord Blood Stem Cell TransplantationCytophagocytosisHematopoiesisVincristineCytarabineDisease-Free SurvivalAntineoplastic AgentsHodgkin DiseaseAmyloidosisTissue DonorsTransplantation ChimeraSurvival RateNeoplasmsRetrospective StudiesDoxorubicinWhole-Body IrradiationBlood Cell CountSurvival AnalysisTime FactorsInfectionPlatelet CountHistocompatibilityRecombinant ProteinsBlood CellsPOEMS SyndromeCarboplatinHistocompatibility TestingImmunosuppressive AgentsLymphoma, T-CellVidarabineLeukemia, Myeloid, AcuteTransplantation, IsogeneicLeukemiaBone Marrow PurgingPrednisoneLymphomaFollow-Up StudiesDexamethasoneProspective StudiesFeasibility StudiesCytomegalovirus InfectionsGraft vs Leukemia EffectFatal OutcomeImmunophenotypingBlood DonorsLeukocytes, MononuclearAnemia, AplasticMyelodysplastic SyndromesBone MarrowHematologic DiseasesBreast NeoplasmsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionLeukocyte CountCell SeparationT-LymphocytesNeutropeniaFlow CytometryHistiocytosis, Non-Langerhans-CellPrognosisEmbryonic Stem CellsBone Marrow DiseasesPrecursor Cell Lymphoblastic Leukemia-LymphomaFeverImmunomagnetic SeparationOpportunistic Infections